Patients with pandemic influenza A (H1N1) 2009 in intensive care
Authors:
Džupová Olga 1; Havlíčková Martina 2; Helcl Miroslav 3; Kabelková Maria 3; Kulichová Jana 3; Roháčová Hana 3; Beneš Jiří 1
Authors‘ workplace:
Univerzita Karlova, 3. lékařská fakulta, Klinika infekčních nemocí, Praha
1; Národní referenční laboratoř pro chřipku, Státní zdravotní ústav, Praha
2; Klinika infekčních nemocí, Fakultní nemocnice Na Bulovce, Praha
3
Published in:
Anest. intenziv. Med., 21, 2010, č. 5, s. 251-257
Category:
Intensive Care Medicine - Original Paper
Overview
Objective:
To describe the epidemiological and clinical characteristics, treatment and clinical outcome of patients with severe pandemic influenza.
Design:
Retrospective observational study.
Setting:
Department of Infectious Diseases, University Hospital.
Materials and methods:
This is a retrospective study of patients hospitalized on the ICU from August 1, 2009, to January 31, 2010, with influenza symptoms and Pandemic A (H1N1) 2009 virus infection confirmed by rtPCR or specific antibody detection.
Results:
Sixteen patients fulfilled the inclusion criteria (9 men and 7 women, aged 21–65 years, median 40). Median time from symptom onset to hospital admission was 5 days; from admission to transfer to the ICU 11 hours; from symptom onset to the start of antiviral therapy 5 days. Eight patients had a chronic underlying condition, 4 of them combined with obesity. Seven patients were obese with BMI > 30. Fever, cough and dyspnoea were the most frequent influenza symptoms. Median APACHE II score was 9.5. The reasons for ICU admission were bilateral pneumonia with acute respiratory failure (13 patients) and acute haemodynamic collapse (3 patients). Conventional mechanical ventilation was required in 9 patients. Two patients with acute renal failure were treated with continuous renal replacement therapy. The mean hospital stay was 25 days, median stay was 19 days. Twelve patients recovered and four died (25%).
Conclusion:
The results confirmed the findings of previous studies: lower age of the patients with severe Pandemic A (H1N1) 2009 virus infection, common absence of comorbid conditions and a high rate of obesity. Primary influenza pneumonia was the prominent cause of the critical condition. A rational choice of antibiotic and antiviral treatment is discussed. The authors conclude that daily dosage of oseltamivir in severe influenza pneumonia should be increased to 300-600 mg.
Keywords:
influenza, Pandemic A (H1N1) 2009, primary influenza pneumonia, respiratory failure
Sources
1. WHO Pandemic (H1N1) 2009 – update 101. Dostupné na www: http://www.who.int/csr/don/2010_05_21/en/index.html
2. Dominguez-Cherit, G., Lapinsky, S. E., Macias, A. E., Pinto, R., Espinosa-Perez, L., de la Torre, A. et al. Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico. JAMA 2009, 302, p. 1880–1887.
3. Gomez-Gomez, A., Magana-Aquino, M., Garcia-Sepulveda, C. A., Ochoa-Perez, U. R., Falcon-Escobedo, R., Comas-Garcia, A. et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San LuisPotosí, Mexico. Emerg. Infect Dis., 2010, 16, p. 27–34.
4. Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J. et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009. N. Engl. J. Med., 2009, 361, p. 1935–1944.
5. Kopel, E., Amitai, Z., Grotto, I., Kaliner, E., Volovik, I. Patients with Pandemic (H1N1) 2009 in intensive care units, Israel. Emerg. Inf. Dis., 2010, 16, p. 720–721.
6. Kumar, A., Zarychanski, R., Pinto, R., Cook, D. J., Marshall, J., Lacroix, J., Stelfox, T. et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA, 2009, 302, p. 1872–1879.
7. Louie, J. K., Acosta, M., Winter, K., Jean, C., Gavali, S., Schechter, R. et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA, 2009, 302, p. 1896–1902.
8. Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quinones-Falconi, F., Bautista, E. et al. Pneumonia and respiratory failure from swine-origin influenza A(H1N1) in Mexico. N. Engl. J. Med., 2009, 361, p. 680–689.
9. Rello, J., Rodriguez, A., Ibanez, P., Socias, L., Cebrian, J., Marques, A. et al. Intensive care adult patients with severe respiratory failure caused by Influena A(H1N1)v in Spain. Crit. Care, 2009, 13, p. R148.
10. Yeung, J. H. Y., Bailey, M., Perkins, G. D., Smith, F. G. Presentation and management of critically ill patients with influenza A(H1N1): a UK perspective. Crit. Care, 2009, 13, p. 426.
11. Zarychanski, R., Stuart, T. L., Kumar, A., Doucette, S., Elliott, L., Kettner, J. et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Canad. Med. Assoc. J., 2010,182, p. 257–264.
12. Webb, S. A., Pettila, V., Seppelt, I., Bellomo, R., Bailey, M., Cooper, D. J. et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl. J. Med., 2009, 361, p. 1925–1934.
13. SZÚ Aktualizované informace – potvrzené případy onemocnění virem “Pandemic (H1N1) 2009” ke dni 3.3. 2010. Dostupné na www: http://www.szu.cz/tema/prevence/aktualizovane-informace-o-potvrzenych-pripadech-onemocneni-2
14. CDC Intensive-care patients with severe novel influenza A (H1N1) virus infection – Michigan, June 2009. MMWR Morb. Mortal Wkly. Rep., 2009, 58, p. 749–752.
15. Mauad, T., Hajjar, L. A., Callegari, G. D., da Silva, L. F., Schout, D., Galas, F. R. et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med., 2010, 181, p. 72–79.
16. CDC Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). 2008, MMWR Morb. Mortal. Wkly. Rep., 57 (No.RR-7).
17. Tamiflu – Souhrn údajů o přípravku. Dostupné na www: http://www.leky.sukl.cz/informace-o-pripravku-tamiflu
18. Petersen, E. Optimal management of severe H1N1. European Congress on Clinical Microbiology and Infectious Diseases, Vienna, 10.–13.4.2010.
19. WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. Dostupné na www: http://www.who.int/csr/resources/ publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf
20. Rello, J., Pop-Vicas, A. Clinical review: Primary influenza viral pneumonia. Critical Care, 2009, 13, p. 235.
21. Intravenous relenza saves swine flu woman. Dostupné na www: http://www.reuters.com/article/idUSL310017920090903
22. Kolek, V. et al. Diagnostika a léčba komunitně získané pneumonie dospělých. Aktualizace 11.4.2007. Dostupné na www: http://www.pneumologie.cz/odborne/doporucene-postupy.php
23. Webové stránky Hygienické stanice hl.m. Prahy; údaje k 4.3.2010. Dostupné na www: http://hygpraha.cz
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2010 Issue 5
Most read in this issue
- Recombinant activated factor VII (rFVIIa) in the treatment of life threatening post-partum haemorrhage – data from the UniSeven clinical registry in the Czech Republic
- Application of recombinant factor VIIa for refractory bleeding in patients with liver trauma – case reports
- Effect of early use of high frequency oscillation in children with respiratory failure
- Patients with pandemic influenza A (H1N1) 2009 in intensive care